Basic Science and Pathogenesis
There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neu...
Gespeichert in:
| Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 Suppl 1, p.e091707 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | e091707 |
| container_title | Alzheimer's & dementia |
| container_volume | 20 Suppl 1 |
| creator | Dacey, Ryan Durape, Shruti Wang, Mengyao Hwang, Phillip H Gurnani, Ashita S Ang, Ting Fang Alvin Devine, Sherral A Choi, Seo-Eun Lee, Michael L Scollard, Phoebe Gibbons, Laura E Mukherjee, Shubhabrata Trittschuh, Emily H Sherva, Richard Dumitrescu, Logan C Hohman, Timothy J Cuccaro, Michael L Saykin, Andrew J Crane, Paul K Li, Yi Levy, Daniel Ma, Jiantao Liu, Chunyu Lunetta, Kathryn L Au, Rhoda Farrer, Lindsay A Mez, Jesse |
| description | There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neuropsychological (NP) factor scores, mild cognitive impairment (MCI), Alzheimer's Disease (AD), and all-cause dementia, before and after accounting for plasma total tau (t-tau), a marker of neurodegeneration.
DNA methylation and plasma t-tau (Simoa assay; Quanterix) data from 2091 Framingham Heart Study Offspring cohort participants were generated from blood at the same Exam 8 visit (2005-2008). Three epigenetic clock measures: DunedinPACE, PC PhenoAge, and PC GrimAge were estimated from the DNA methylation data. Longitudinal NP factor scores were previously derived for memory, language, and executive function using confirmatory factor analysis. We tested the association of epigenetic age acceleration with cognitive trajectories using linear mixed effects models and with time to MCI, all-cause dementia and AD using Cox-proportional hazard models. Models were run with and without adjustment for plasma t-tau. All models included APOE ε4-carrier status, education, smoking, age, and sex as covariates. Epigenetic measures were standardized in all models.
At Exam 8, the sample was, on average, 66.3 (SD = 9.0) years of age, 54.8% female, and had 16.4 (SD = 2.7) years of education. DundeinPACE was significantly associated with faster decline in executive function (β
= -0.005, 95% CI:[-0.009,-0.002], p = 0.0020), but not with baseline executive function. Older PhenoAge (β
= -0.041, 95% CI:[-0.067,-0.014], p = 0.0028) and GrimAge (β
= -0.042, 95% CI:[-0.073,-0.011], p = 0.0084) were significantly associated with worse baseline executive function, but not with rate of decline. Older PhenoAge also was significantly associated with worse baseline memory (β
= -0.037, 95% CI:[-0.061,-0.012], p = 0.0036). DunedinPACE was significantly associated with time to MCI (HR = 1.20, 95% CI:[1.06,1.35], p = 0.0034), AD (HR = 1.30, 95% CI:[1.07,1.57], p = 0.0068) and all-cause dementia (HR = 1.30, 95% CI:[1.10,1.53], p = 0.0017). Results remained similar after adjustment for plasma t-tau.
Epigenetic age acceleration may be a marker of cognitive resilience, particularly in executive function. Of the three epigenetic clocks examined, DundedinPACE showed the most robust associations with cogn |
| doi_str_mv | 10.1002/alz.091707 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3151210543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151210543</sourcerecordid><originalsourceid>FETCH-LOGICAL-p564-348be8f85ab00a7e4fedc074ba00cdb88d62f26e613be5b06f81a3f662d9633d3</originalsourceid><addsrcrecordid>eNpNj8lKA0EURQtRTIxu_IDQSzcdX83VSw1OEFAw-6aGV1rSk13phX69ihFc3bs4HO4l5JzCigKwS9t8rqCiGvQBmVMpWSmZrg7_9Rk5yfkNQICh8pjMeKUlZVTMyfLa5uSLZ5-w81jYLhRPdvfav2CHOeVTchRtk_Fsnwuyvb3Zru_LzePdw_pqUw5SiZIL49BEI60DsBpFxOBBC2cBfHDGBMUiU6godygdqGio5VEpFirFeeALcvGrHcb-fcK8q9uUPTaN7bCfcs3pz1yQgn-jyz06uRZDPYypteNH_XeJfwHuGksA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151210543</pqid></control><display><type>article</type><title>Basic Science and Pathogenesis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>PubMed Central Open Access</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><creator>Dacey, Ryan ; Durape, Shruti ; Wang, Mengyao ; Hwang, Phillip H ; Gurnani, Ashita S ; Ang, Ting Fang Alvin ; Devine, Sherral A ; Choi, Seo-Eun ; Lee, Michael L ; Scollard, Phoebe ; Gibbons, Laura E ; Mukherjee, Shubhabrata ; Trittschuh, Emily H ; Sherva, Richard ; Dumitrescu, Logan C ; Hohman, Timothy J ; Cuccaro, Michael L ; Saykin, Andrew J ; Crane, Paul K ; Li, Yi ; Levy, Daniel ; Ma, Jiantao ; Liu, Chunyu ; Lunetta, Kathryn L ; Au, Rhoda ; Farrer, Lindsay A ; Mez, Jesse</creator><creatorcontrib>Dacey, Ryan ; Durape, Shruti ; Wang, Mengyao ; Hwang, Phillip H ; Gurnani, Ashita S ; Ang, Ting Fang Alvin ; Devine, Sherral A ; Choi, Seo-Eun ; Lee, Michael L ; Scollard, Phoebe ; Gibbons, Laura E ; Mukherjee, Shubhabrata ; Trittschuh, Emily H ; Sherva, Richard ; Dumitrescu, Logan C ; Hohman, Timothy J ; Cuccaro, Michael L ; Saykin, Andrew J ; Crane, Paul K ; Li, Yi ; Levy, Daniel ; Ma, Jiantao ; Liu, Chunyu ; Lunetta, Kathryn L ; Au, Rhoda ; Farrer, Lindsay A ; Mez, Jesse</creatorcontrib><description>There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neuropsychological (NP) factor scores, mild cognitive impairment (MCI), Alzheimer's Disease (AD), and all-cause dementia, before and after accounting for plasma total tau (t-tau), a marker of neurodegeneration.
DNA methylation and plasma t-tau (Simoa assay; Quanterix) data from 2091 Framingham Heart Study Offspring cohort participants were generated from blood at the same Exam 8 visit (2005-2008). Three epigenetic clock measures: DunedinPACE, PC PhenoAge, and PC GrimAge were estimated from the DNA methylation data. Longitudinal NP factor scores were previously derived for memory, language, and executive function using confirmatory factor analysis. We tested the association of epigenetic age acceleration with cognitive trajectories using linear mixed effects models and with time to MCI, all-cause dementia and AD using Cox-proportional hazard models. Models were run with and without adjustment for plasma t-tau. All models included APOE ε4-carrier status, education, smoking, age, and sex as covariates. Epigenetic measures were standardized in all models.
At Exam 8, the sample was, on average, 66.3 (SD = 9.0) years of age, 54.8% female, and had 16.4 (SD = 2.7) years of education. DundeinPACE was significantly associated with faster decline in executive function (β
= -0.005, 95% CI:[-0.009,-0.002], p = 0.0020), but not with baseline executive function. Older PhenoAge (β
= -0.041, 95% CI:[-0.067,-0.014], p = 0.0028) and GrimAge (β
= -0.042, 95% CI:[-0.073,-0.011], p = 0.0084) were significantly associated with worse baseline executive function, but not with rate of decline. Older PhenoAge also was significantly associated with worse baseline memory (β
= -0.037, 95% CI:[-0.061,-0.012], p = 0.0036). DunedinPACE was significantly associated with time to MCI (HR = 1.20, 95% CI:[1.06,1.35], p = 0.0034), AD (HR = 1.30, 95% CI:[1.07,1.57], p = 0.0068) and all-cause dementia (HR = 1.30, 95% CI:[1.10,1.53], p = 0.0017). Results remained similar after adjustment for plasma t-tau.
Epigenetic age acceleration may be a marker of cognitive resilience, particularly in executive function. Of the three epigenetic clocks examined, DundedinPACE showed the most robust associations with cognitive resilience, with lower DunedinPACE associated with greater cognitive resilience.</description><identifier>ISSN: 1552-5279</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.091707</identifier><identifier>PMID: 39751214</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Aging - genetics ; Aging - physiology ; Alzheimer Disease - genetics ; Biomarkers - blood ; Cognitive Dysfunction - genetics ; Cohort Studies ; Dementia - genetics ; DNA Methylation ; Epigenesis, Genetic ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Neuropsychological Tests - statistics & numerical data ; tau Proteins</subject><ispartof>Alzheimer's & dementia, 2024-12, Vol.20 Suppl 1, p.e091707</ispartof><rights>2024 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39751214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dacey, Ryan</creatorcontrib><creatorcontrib>Durape, Shruti</creatorcontrib><creatorcontrib>Wang, Mengyao</creatorcontrib><creatorcontrib>Hwang, Phillip H</creatorcontrib><creatorcontrib>Gurnani, Ashita S</creatorcontrib><creatorcontrib>Ang, Ting Fang Alvin</creatorcontrib><creatorcontrib>Devine, Sherral A</creatorcontrib><creatorcontrib>Choi, Seo-Eun</creatorcontrib><creatorcontrib>Lee, Michael L</creatorcontrib><creatorcontrib>Scollard, Phoebe</creatorcontrib><creatorcontrib>Gibbons, Laura E</creatorcontrib><creatorcontrib>Mukherjee, Shubhabrata</creatorcontrib><creatorcontrib>Trittschuh, Emily H</creatorcontrib><creatorcontrib>Sherva, Richard</creatorcontrib><creatorcontrib>Dumitrescu, Logan C</creatorcontrib><creatorcontrib>Hohman, Timothy J</creatorcontrib><creatorcontrib>Cuccaro, Michael L</creatorcontrib><creatorcontrib>Saykin, Andrew J</creatorcontrib><creatorcontrib>Crane, Paul K</creatorcontrib><creatorcontrib>Li, Yi</creatorcontrib><creatorcontrib>Levy, Daniel</creatorcontrib><creatorcontrib>Ma, Jiantao</creatorcontrib><creatorcontrib>Liu, Chunyu</creatorcontrib><creatorcontrib>Lunetta, Kathryn L</creatorcontrib><creatorcontrib>Au, Rhoda</creatorcontrib><creatorcontrib>Farrer, Lindsay A</creatorcontrib><creatorcontrib>Mez, Jesse</creatorcontrib><title>Basic Science and Pathogenesis</title><title>Alzheimer's & dementia</title><addtitle>Alzheimers Dement</addtitle><description>There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neuropsychological (NP) factor scores, mild cognitive impairment (MCI), Alzheimer's Disease (AD), and all-cause dementia, before and after accounting for plasma total tau (t-tau), a marker of neurodegeneration.
DNA methylation and plasma t-tau (Simoa assay; Quanterix) data from 2091 Framingham Heart Study Offspring cohort participants were generated from blood at the same Exam 8 visit (2005-2008). Three epigenetic clock measures: DunedinPACE, PC PhenoAge, and PC GrimAge were estimated from the DNA methylation data. Longitudinal NP factor scores were previously derived for memory, language, and executive function using confirmatory factor analysis. We tested the association of epigenetic age acceleration with cognitive trajectories using linear mixed effects models and with time to MCI, all-cause dementia and AD using Cox-proportional hazard models. Models were run with and without adjustment for plasma t-tau. All models included APOE ε4-carrier status, education, smoking, age, and sex as covariates. Epigenetic measures were standardized in all models.
At Exam 8, the sample was, on average, 66.3 (SD = 9.0) years of age, 54.8% female, and had 16.4 (SD = 2.7) years of education. DundeinPACE was significantly associated with faster decline in executive function (β
= -0.005, 95% CI:[-0.009,-0.002], p = 0.0020), but not with baseline executive function. Older PhenoAge (β
= -0.041, 95% CI:[-0.067,-0.014], p = 0.0028) and GrimAge (β
= -0.042, 95% CI:[-0.073,-0.011], p = 0.0084) were significantly associated with worse baseline executive function, but not with rate of decline. Older PhenoAge also was significantly associated with worse baseline memory (β
= -0.037, 95% CI:[-0.061,-0.012], p = 0.0036). DunedinPACE was significantly associated with time to MCI (HR = 1.20, 95% CI:[1.06,1.35], p = 0.0034), AD (HR = 1.30, 95% CI:[1.07,1.57], p = 0.0068) and all-cause dementia (HR = 1.30, 95% CI:[1.10,1.53], p = 0.0017). Results remained similar after adjustment for plasma t-tau.
Epigenetic age acceleration may be a marker of cognitive resilience, particularly in executive function. Of the three epigenetic clocks examined, DundedinPACE showed the most robust associations with cognitive resilience, with lower DunedinPACE associated with greater cognitive resilience.</description><subject>Aged</subject><subject>Aging - genetics</subject><subject>Aging - physiology</subject><subject>Alzheimer Disease - genetics</subject><subject>Biomarkers - blood</subject><subject>Cognitive Dysfunction - genetics</subject><subject>Cohort Studies</subject><subject>Dementia - genetics</subject><subject>DNA Methylation</subject><subject>Epigenesis, Genetic</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests - statistics & numerical data</subject><subject>tau Proteins</subject><issn>1552-5279</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj8lKA0EURQtRTIxu_IDQSzcdX83VSw1OEFAw-6aGV1rSk13phX69ihFc3bs4HO4l5JzCigKwS9t8rqCiGvQBmVMpWSmZrg7_9Rk5yfkNQICh8pjMeKUlZVTMyfLa5uSLZ5-w81jYLhRPdvfav2CHOeVTchRtk_Fsnwuyvb3Zru_LzePdw_pqUw5SiZIL49BEI60DsBpFxOBBC2cBfHDGBMUiU6godygdqGio5VEpFirFeeALcvGrHcb-fcK8q9uUPTaN7bCfcs3pz1yQgn-jyz06uRZDPYypteNH_XeJfwHuGksA</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Dacey, Ryan</creator><creator>Durape, Shruti</creator><creator>Wang, Mengyao</creator><creator>Hwang, Phillip H</creator><creator>Gurnani, Ashita S</creator><creator>Ang, Ting Fang Alvin</creator><creator>Devine, Sherral A</creator><creator>Choi, Seo-Eun</creator><creator>Lee, Michael L</creator><creator>Scollard, Phoebe</creator><creator>Gibbons, Laura E</creator><creator>Mukherjee, Shubhabrata</creator><creator>Trittschuh, Emily H</creator><creator>Sherva, Richard</creator><creator>Dumitrescu, Logan C</creator><creator>Hohman, Timothy J</creator><creator>Cuccaro, Michael L</creator><creator>Saykin, Andrew J</creator><creator>Crane, Paul K</creator><creator>Li, Yi</creator><creator>Levy, Daniel</creator><creator>Ma, Jiantao</creator><creator>Liu, Chunyu</creator><creator>Lunetta, Kathryn L</creator><creator>Au, Rhoda</creator><creator>Farrer, Lindsay A</creator><creator>Mez, Jesse</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Basic Science and Pathogenesis</title><author>Dacey, Ryan ; Durape, Shruti ; Wang, Mengyao ; Hwang, Phillip H ; Gurnani, Ashita S ; Ang, Ting Fang Alvin ; Devine, Sherral A ; Choi, Seo-Eun ; Lee, Michael L ; Scollard, Phoebe ; Gibbons, Laura E ; Mukherjee, Shubhabrata ; Trittschuh, Emily H ; Sherva, Richard ; Dumitrescu, Logan C ; Hohman, Timothy J ; Cuccaro, Michael L ; Saykin, Andrew J ; Crane, Paul K ; Li, Yi ; Levy, Daniel ; Ma, Jiantao ; Liu, Chunyu ; Lunetta, Kathryn L ; Au, Rhoda ; Farrer, Lindsay A ; Mez, Jesse</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p564-348be8f85ab00a7e4fedc074ba00cdb88d62f26e613be5b06f81a3f662d9633d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aging - genetics</topic><topic>Aging - physiology</topic><topic>Alzheimer Disease - genetics</topic><topic>Biomarkers - blood</topic><topic>Cognitive Dysfunction - genetics</topic><topic>Cohort Studies</topic><topic>Dementia - genetics</topic><topic>DNA Methylation</topic><topic>Epigenesis, Genetic</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests - statistics & numerical data</topic><topic>tau Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dacey, Ryan</creatorcontrib><creatorcontrib>Durape, Shruti</creatorcontrib><creatorcontrib>Wang, Mengyao</creatorcontrib><creatorcontrib>Hwang, Phillip H</creatorcontrib><creatorcontrib>Gurnani, Ashita S</creatorcontrib><creatorcontrib>Ang, Ting Fang Alvin</creatorcontrib><creatorcontrib>Devine, Sherral A</creatorcontrib><creatorcontrib>Choi, Seo-Eun</creatorcontrib><creatorcontrib>Lee, Michael L</creatorcontrib><creatorcontrib>Scollard, Phoebe</creatorcontrib><creatorcontrib>Gibbons, Laura E</creatorcontrib><creatorcontrib>Mukherjee, Shubhabrata</creatorcontrib><creatorcontrib>Trittschuh, Emily H</creatorcontrib><creatorcontrib>Sherva, Richard</creatorcontrib><creatorcontrib>Dumitrescu, Logan C</creatorcontrib><creatorcontrib>Hohman, Timothy J</creatorcontrib><creatorcontrib>Cuccaro, Michael L</creatorcontrib><creatorcontrib>Saykin, Andrew J</creatorcontrib><creatorcontrib>Crane, Paul K</creatorcontrib><creatorcontrib>Li, Yi</creatorcontrib><creatorcontrib>Levy, Daniel</creatorcontrib><creatorcontrib>Ma, Jiantao</creatorcontrib><creatorcontrib>Liu, Chunyu</creatorcontrib><creatorcontrib>Lunetta, Kathryn L</creatorcontrib><creatorcontrib>Au, Rhoda</creatorcontrib><creatorcontrib>Farrer, Lindsay A</creatorcontrib><creatorcontrib>Mez, Jesse</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer's & dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dacey, Ryan</au><au>Durape, Shruti</au><au>Wang, Mengyao</au><au>Hwang, Phillip H</au><au>Gurnani, Ashita S</au><au>Ang, Ting Fang Alvin</au><au>Devine, Sherral A</au><au>Choi, Seo-Eun</au><au>Lee, Michael L</au><au>Scollard, Phoebe</au><au>Gibbons, Laura E</au><au>Mukherjee, Shubhabrata</au><au>Trittschuh, Emily H</au><au>Sherva, Richard</au><au>Dumitrescu, Logan C</au><au>Hohman, Timothy J</au><au>Cuccaro, Michael L</au><au>Saykin, Andrew J</au><au>Crane, Paul K</au><au>Li, Yi</au><au>Levy, Daniel</au><au>Ma, Jiantao</au><au>Liu, Chunyu</au><au>Lunetta, Kathryn L</au><au>Au, Rhoda</au><au>Farrer, Lindsay A</au><au>Mez, Jesse</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Basic Science and Pathogenesis</atitle><jtitle>Alzheimer's & dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2024-12</date><risdate>2024</risdate><volume>20 Suppl 1</volume><spage>e091707</spage><pages>e091707-</pages><issn>1552-5279</issn><eissn>1552-5279</eissn><abstract>There is growing evidence that epigenetic age acceleration may predict late life cognitive decline and dementia, but it is unknown whether this is due to accelerated neurodegeneration or reduction in cognitive resilience. We examined the relationship between epigenetic clocks and domain specific neuropsychological (NP) factor scores, mild cognitive impairment (MCI), Alzheimer's Disease (AD), and all-cause dementia, before and after accounting for plasma total tau (t-tau), a marker of neurodegeneration.
DNA methylation and plasma t-tau (Simoa assay; Quanterix) data from 2091 Framingham Heart Study Offspring cohort participants were generated from blood at the same Exam 8 visit (2005-2008). Three epigenetic clock measures: DunedinPACE, PC PhenoAge, and PC GrimAge were estimated from the DNA methylation data. Longitudinal NP factor scores were previously derived for memory, language, and executive function using confirmatory factor analysis. We tested the association of epigenetic age acceleration with cognitive trajectories using linear mixed effects models and with time to MCI, all-cause dementia and AD using Cox-proportional hazard models. Models were run with and without adjustment for plasma t-tau. All models included APOE ε4-carrier status, education, smoking, age, and sex as covariates. Epigenetic measures were standardized in all models.
At Exam 8, the sample was, on average, 66.3 (SD = 9.0) years of age, 54.8% female, and had 16.4 (SD = 2.7) years of education. DundeinPACE was significantly associated with faster decline in executive function (β
= -0.005, 95% CI:[-0.009,-0.002], p = 0.0020), but not with baseline executive function. Older PhenoAge (β
= -0.041, 95% CI:[-0.067,-0.014], p = 0.0028) and GrimAge (β
= -0.042, 95% CI:[-0.073,-0.011], p = 0.0084) were significantly associated with worse baseline executive function, but not with rate of decline. Older PhenoAge also was significantly associated with worse baseline memory (β
= -0.037, 95% CI:[-0.061,-0.012], p = 0.0036). DunedinPACE was significantly associated with time to MCI (HR = 1.20, 95% CI:[1.06,1.35], p = 0.0034), AD (HR = 1.30, 95% CI:[1.07,1.57], p = 0.0068) and all-cause dementia (HR = 1.30, 95% CI:[1.10,1.53], p = 0.0017). Results remained similar after adjustment for plasma t-tau.
Epigenetic age acceleration may be a marker of cognitive resilience, particularly in executive function. Of the three epigenetic clocks examined, DundedinPACE showed the most robust associations with cognitive resilience, with lower DunedinPACE associated with greater cognitive resilience.</abstract><cop>United States</cop><pmid>39751214</pmid><doi>10.1002/alz.091707</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1552-5279 |
| ispartof | Alzheimer's & dementia, 2024-12, Vol.20 Suppl 1, p.e091707 |
| issn | 1552-5279 1552-5279 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3151210543 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; PubMed Central Open Access; Wiley Online Library Open Access; PubMed Central |
| subjects | Aged Aging - genetics Aging - physiology Alzheimer Disease - genetics Biomarkers - blood Cognitive Dysfunction - genetics Cohort Studies Dementia - genetics DNA Methylation Epigenesis, Genetic Female Humans Longitudinal Studies Male Middle Aged Neuropsychological Tests - statistics & numerical data tau Proteins |
| title | Basic Science and Pathogenesis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T17%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Basic%20Science%20and%20Pathogenesis&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Dacey,%20Ryan&rft.date=2024-12&rft.volume=20%20Suppl%201&rft.spage=e091707&rft.pages=e091707-&rft.issn=1552-5279&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.091707&rft_dat=%3Cproquest_pubme%3E3151210543%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151210543&rft_id=info:pmid/39751214&rfr_iscdi=true |